MANNATECH INC (MTEX) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.27%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.27% | Share-based compensation / revenue. Period ending 2026-06-30. $286.00K ÷ $107.36M × 100 ≈ 0.27% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 107.36M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 286.00K USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 2.67M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $107.36M | $286.00K | $2.67M | (m) | (m) | 0.27% | (m) | (m) |
| 2026-03-31 | (m) | $106.39M | $390.00K | $227.00K | (m) | (m) | 0.37% | (m) | (m) |
| 2025-12-31 | $800.00K | $108.04M | $379.00K | $-426.00K | (m) | 0.74% | 0.35% | (m) | (m) |
| 2025-09-30 | (m) | $110.41M | $369.00K | $595.00K | (m) | (m) | 0.33% | (m) | (m) |
| 2025-06-30 | (m) | $112.97M | $466.00K | $-525.00K | (m) | (m) | 0.41% | (m) | (m) |
| 2025-03-31 | (m) | $115.04M | $342.00K | $-224.00K | (m) | (m) | 0.30% | (m) | (m) |
| 2024-12-31 | $700.00K | $117.87M | $291.00K | $1.43M | (m) | 0.59% | 0.25% | (m) | (m) |
| 2024-09-30 | (m) | $121.55M | $288.00K | $-330.00K | (m) | (m) | 0.24% | (m) | (m) |
| 2024-06-30 | (m) | $122.38M | $273.00K | $-1.04M | (m) | (m) | 0.22% | (m) | (m) |
| 2024-03-31 | (m) | $127.23M | $256.00K | $-857.00K | (m) | (m) | 0.20% | (m) | (m) |
| 2023-12-31 | $800.00K | $131.96M | $278.00K | $-964.00K | (m) | 0.61% | 0.21% | (m) | (m) |
| 2023-09-30 | (m) | $133.60M | $290.00K | $-2.72M | (m) | (m) | 0.22% | (m) | (m) |
| 2023-06-30 | (m) | $136.56M | $293.00K | $-1.53M | (m) | (m) | 0.21% | (m) | (m) |
| 2023-03-31 | (m) | $138.94M | $324.00K | $273.00K | (m) | (m) | 0.23% | (m) | (m) |
| 2022-12-31 | $1.00M | $137.21M | $337.00K | $-405.00K | (m) | 0.73% | 0.25% | (m) | (m) |
| 2022-09-30 | (m) | $142.37M | $314.00K | $3.20M | (m) | (m) | 0.22% | (m) | (m) |
| 2022-06-30 | (m) | $146.30M | $310.00K | $5.13M | (m) | (m) | 0.21% | (m) | (m) |
| 2022-03-31 | (m) | $153.83M | $291.00K | $6.29M | (m) | (m) | 0.19% | (m) | (m) |
| 2021-12-31 | $1.20M | $159.76M | $260.00K | $9.05M | (m) | 0.75% | 0.16% | (m) | (m) |
| 2021-09-30 | (m) | $159.46M | $258.00K | $8.08M | (m) | (m) | 0.16% | (m) | (m) |
| 2021-06-30 | (m) | $157.98M | $252.00K | $6.18M | (m) | (m) | 0.16% | (m) | (m) |
| 2021-03-31 | (m) | $153.12M | $258.00K | $5.27M | (m) | (m) | 0.17% | (m) | (m) |
| 2020-12-31 | $800.00K | $151.41M | $334.00K | $4.49M | (m) | 0.53% | 0.22% | (m) | (m) |
| 2020-09-30 | (m) | $151.61M | $409.00K | $7.23M | (m) | (m) | 0.27% | (m) | (m) |
| 2020-06-30 | (m) | $153.30M | $514.00K | $6.42M | (m) | (m) | 0.34% | (m) | (m) |
| 2020-03-31 | (m) | $156.36M | $638.00K | $7.32M | (m) | (m) | 0.41% | (m) | (m) |
| 2019-12-31 | $1.10M | $157.73M | $734.00K | $6.43M | (m) | 0.70% | 0.47% | (m) | (m) |
| 2019-09-30 | (m) | $162.41M | $789.00K | $3.18M | (m) | (m) | 0.49% | (m) | (m) |
| 2019-06-30 | (m) | $165.76M | $821.00K | $4.29M | (m) | (m) | 0.50% | (m) | (m) |
| 2019-03-31 | (m) | $170.19M | $1.25M | $1.92M | (m) | (m) | 0.74% | (m) | (m) |
| 2018-12-31 | $1.00M | $173.60M | $1.15M | $-90.00K | (m) | 0.58% | 0.66% | (m) | (m) |
| 2018-09-30 | (m) | (m) | $1.05M | $1.48M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | $973.00K | $497.00K | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | $449.00K | $3.67M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $1.20M | $176.70M | $490.00K | $2.52M | (m) | 0.68% | 0.28% | (m) | (m) |
| 2017-09-30 | (m) | (m) | $660.00K | $1.24M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | $718.00K | $1.06M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | $794.00K | $-1.87M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $1.40M | $180.30M | $690.00K | $698.00K | (m) | 0.78% | 0.38% | (m) | (m) |
| 2016-09-30 | (m) | (m) | $616.00K | $3.72M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | $651.00K | $5.45M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $176.60M | $669.00K | $10.17M | (m) | (m) | 0.38% | (m) | (m) |
| 2015-12-31 | $1.70M | $180.30M | $592.00K | $12.14M | (m) | 0.94% | 0.33% | (m) | (m) |
| 2015-09-30 | (m) | $180.20M | $731.00K | $11.92M | (m) | (m) | 0.41% | (m) | (m) |
| 2015-06-30 | (m) | $191.90M | $677.00K | $17.88M | (m) | (m) | 0.35% | (m) | (m) |
| 2015-03-31 | (m) | $191.50M | $641.00K | $13.87M | (m) | (m) | 0.33% | (m) | (m) |
| 2014-12-31 | $1.60M | $190.10M | $678.00K | $12.74M | (m) | 0.84% | 0.36% | (m) | (m) |
| 2014-09-30 | (m) | $191.40M | $433.00K | $12.30M | (m) | (m) | 0.23% | (m) | (m) |
| 2014-06-30 | (m) | $180.20M | $379.00K | $4.53M | (m) | (m) | 0.21% | (m) | (m) |
| 2014-03-31 | (m) | $178.70M | $314.00K | $5.48M | (m) | (m) | 0.18% | (m) | (m) |
| 2013-12-31 | $1.60M | $177.40M | $173.00K | $4.76M | (m) | 0.90% | 0.10% | (m) | (m) |
| 2013-09-30 | (m) | $173.20M | $179.00K | $4.03M | (m) | (m) | 0.10% | (m) | (m) |
| 2013-06-30 | (m) | $171.80M | $181.00K | $4.69M | (m) | (m) | 0.11% | (m) | (m) |
| 2013-03-31 | (m) | $170.60M | $196.00K | $1.73M | (m) | (m) | 0.11% | (m) | (m) |
| 2012-12-31 | $1.90M | $173.40M | $209.00K | $-980.00K | (m) | 1.10% | 0.12% | (m) | (m) |
| 2012-09-30 | (m) | (m) | $243.00K | $-8.46M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | $278.00K | $-11.12M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | $309.00K | $-14.04M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | $356.00K | $-16.89M | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | $446.00K | $-13.60M | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | $441.00K | $-15.69M | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | $518.00K | $-13.49M | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $630.00K | $-11.48M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | $663.00K | $-8.97M | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $715.00K | $-13.88M | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | $706.00K | $-22.81M | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $636.00K | $-25.59M | (m) | (m) | (m) | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $727.00K | $-14.50M | (m) | (m) | (m) | (m) | (m) |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | $948.00K | $7.61M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |